结核分枝杆菌的耐药性趋势：布莱克本，1985 - 1989年
Drug resistance trends in Mycobacterium tuberculosis: Blackburn 1985-89.
作者信息
Ormerod L P, Harrison J M, Wright P A
机构信息
Chest Clinic, Blackburn Royal Infirmary, Lancs, UK.
出版信息
Tubercle. 1990 Dec;71(4):283-5. doi: 10.1016/0041-3879(90)90042-7.
PMID:2125155
Abstract
Drug resistance in Mycobacterium tuberculosis fell from 15.2% in 1980-1984 to 6.5% in 1985-89 in the Indian subcontinent (ISC) ethnic group and remained low in the white ethnic group. Resistance to isoniazid, which is of particular clinical significance, fell from 6.1% in 1980-84 to 2.7% in 1985-1989 in the ISC group. Factors which may affect this trend to reduction are discussed.
摘要
在印度次大陆（ISC）族群中，结核分枝杆菌的耐药率从1980 - 1984年的15.2%降至1985 - 1989年的6.5%，而在白种人族群中耐药率一直较低。对具有特殊临床意义的异烟肼的耐药率，在ISC族群中从1980 - 1984年的6.1%降至1985 - 1989年的2.7%。文中讨论了可能影响这一下降趋势的因素。
相似文献
1
Drug resistance trends in Mycobacterium tuberculosis: Blackburn 1985-89.结核分枝杆菌的耐药性趋势：布莱克本，1985 - 1989年
Tubercle. 1990 Dec;71(4):283-5. doi: 10.1016/0041-3879(90)90042-7.
2
Drug resistance trends in M. tuberculosis: Blackburn 1990-1999.结核分枝杆菌的耐药性趋势：布莱克本，1990 - 1999年
Int J Tuberc Lung Dis. 2001 Oct;5(10):903-5.
3
Drug resistance in Mycobacterium tuberculosis: a survey over 25 years in Blackburn.结核分枝杆菌的耐药性：布莱克本25年的调查
Thorax. 1986 Dec;41(12):946-50. doi: 10.1136/thx.41.12.946.
4
National survey of tuberculosis notifications in England and Wales in 1983: characteristics of disease. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit.1983年英格兰和威尔士结核病通报情况的全国性调查：疾病特征。医学研究理事会结核病与胸部疾病研究室报告
Tubercle. 1987 Mar;68(1):19-32. doi: 10.1016/0041-3879(87)90004-3.
5
Presence of katG gene in resistant Mycobacterium tuberculosis.耐药结核分枝杆菌中katG基因的存在。
J Clin Pathol. 1996 Nov;49(11):945-7. doi: 10.1136/jcp.49.11.945.
6
Primary drug resistance to Mycobacterium tuberculosis in renal transplant recipients.肾移植受者对结核分枝杆菌的原发性耐药性。
Natl Med J India. 1995 Sep-Oct;8(5):211-2.
7
[Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].[罗马尼亚不同地区结核分枝杆菌（MT）菌株耐药突变体的发生率。细菌学研究——流行病学方面]
Arch Roum Pathol Exp Microbiol. 1970 Mar-Jun;29(1):212-22.
8
Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.墨西哥西部结核分枝杆菌的原发性和获得性耐药性。
Microb Drug Resist. 2000 Summer;6(2):143-5. doi: 10.1089/107662900419456.
9
Trends in drug resistance of mycobacterium tuberculosis.
Indian J Chest Dis Allied Sci. 1982 Apr-Sep;24(2-3):190-4.
10
Drug resistance of Mycobacterium tuberculosis in Chandigarh.昌迪加尔结核分枝杆菌的耐药性
Indian J Med Res. 1968 Aug;56(8):1180-7.
引用本文的文献
1
In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.硝基咪唑类化合物CGI 17341对结核分枝杆菌的体外和体内活性
Antimicrob Agents Chemother. 1993 Feb;37(2):183-6. doi: 10.1128/AAC.37.2.183.
2
Drug resistant tuberculosis: problems on the horizon.耐药结核病：即将出现的问题。
Thorax. 1993 Oct;48(10):957-8. doi: 10.1136/thx.48.10.957.
Zotero 插件